Sven Hoffner Selected Research

Injections

12/2016	A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
9/2015	Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
12/2013	Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
8/2013	Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven Hoffner Research Topics

Disease

27	Tuberculosis (Tuberculoses) 01/2023 - 06/2002
10	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 12/2010
3	Infections 01/2022 - 01/2011
3	Extensively Drug-Resistant Tuberculosis 12/2013 - 02/2008
3	Multiple Organ Failure (MODS) 09/2013 - 05/2009
2	Pulmonary Tuberculosis 01/2014 - 06/2009
1	Lung Diseases (Lung Disease) 01/2023
1	Genomic Instability 01/2011
1	Infection with Mycobacterium marinum 01/2011
1	Persistent Infection 01/2011

Drug/Important Bio-Agent (IBA)

11	Rifampin (Rifampicin)FDA LinkGeneric 01/2023 - 01/2005
10	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018 - 06/2002
7	FluoroquinolonesIBA 06/2020 - 08/2013
6	Pyrazinamide FDA LinkGeneric 12/2021 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2011
3	Moxifloxacin (Avelox)FDA Link 01/2021 - 01/2014
3	Nitrate ReductaseIBA 09/2013 - 05/2009
2	Antitubercular AgentsIBA 04/2017 - 12/2016
2	bedaquiline (R207910)IBA 12/2016 - 01/2005
2	EnzymesIBA 01/2014 - 01/2011
2	Indicators and Reagents (Reagents)IBA 09/2013 - 02/2008
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2018
1	DiarylquinolinesIBA 12/2016
1	AgarIBA 12/2016
1	ebselenIBA 06/2016
1	Adenosine Triphosphatases (ATPase)IBA 01/2014
1	DNA GyraseIBA 01/2014
1	arabinogalactanIBA 04/2012
1	Mycolic Acids (Mycolic Acid)IBA 04/2012
1	ethyl 4-methoxycinnamateIBA 07/2011
1	leukotriene A4 hydrolaseIBA 01/2011
1	EicosanoidsIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	resazurinIBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2009
1	natural resistance-associated macrophage protein 1IBA 08/2009
1	malachite greenIBA 02/2008
1	Coloring Agents (Dyes)IBA 02/2008
1	Antimicrobial PeptidesIBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	streptolysin OIBA 07/2006

Therapy/Procedure

4	Injections 12/2016 - 08/2013
3	Therapeutics 12/2017 - 06/2009